1. Targeted blocking of CCR2 and CXCR2 improves the efficacy of transarterial chemoembolization of hepatocarcinoma
    Zhiqiang Tian et al, 2022, Cancer Cell International CrossRef
  2. The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression
    Ciniso Sylvester Shabangu et al, 2021, Biomedicines CrossRef
  3. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma
    Zhan Yang et al, 2022, BMC Cancer CrossRef
  4. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers
    Guoying Zhou et al, 2022, British Journal of Cancer CrossRef
  5. Significance of exosomes in hepatocellular carcinoma
    GuoYun Wang et al, 2022, Frontiers in Oncology CrossRef
  6. Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment
    Alessandro Granito et al, 2021, World Journal of Gastroenterology CrossRef
  7. Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
    Xuemei Yang et al, 2021, Frontiers in Pharmacology CrossRef
  8. Investigation of Anti-Liver Cancer Activity of the Herbal Drug FDY003 Using Network Pharmacology
    Ho-Sung Lee et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  9. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
    Mudassier Ahmad et al, 2022, Seminars in Cancer Biology CrossRef
  10. Chemokines in Primary Liver Cancer
    Monika Zajkowska et al, 2022, International Journal of Molecular Sciences CrossRef
  11. Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
    Juan Wang et al, 2022, Frontiers in Oncology CrossRef
  12. A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma
    Xing Lai et al, 2022, Journal of Immunology Research CrossRef